ReviewDiabetology & metabolic syndrome2025

The impact of semaglutide on liver outcomes in patients with or at risk of MASH: a dose and duration response meta-analysis of randomized trials.

Ranran Kan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.